
### [NCIT:C4122](http://purl.obolibrary.org/obo/NCIT_C4122)
**Label:** Papillary Transitional Cell Carcinoma

**Subclasses:** [NCIT:C7517](http://purl.obolibrary.org/obo/NCIT_C7517) (Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C6148](http://purl.obolibrary.org/obo/NCIT_C6148) (Renal Pelvis Papillary Urothelial Carcinoma), [NCIT:C6203](http://purl.obolibrary.org/obo/NCIT_C6203) (Stage 0a Ureter Urothelial Carcinoma), [NCIT:C6202](http://purl.obolibrary.org/obo/NCIT_C6202) (Stage 0a Renal Pelvis Urothelial Carcinoma), [NCIT:C7383](http://purl.obolibrary.org/obo/NCIT_C7383) (Bladder Papillary Urothelial Carcinoma), [NCIT:C9267](http://purl.obolibrary.org/obo/NCIT_C9267) (Stage 0a Bladder Urothelial Carcinoma), [NCIT:C65181](http://purl.obolibrary.org/obo/NCIT_C65181) (Non-Invasive Papillary Transitional Cell Carcinoma), [NCIT:C27876](http://purl.obolibrary.org/obo/NCIT_C27876) (Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade), 

**Class expressions from DL-Learner:**

- [NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression) 54.17%
- [NCIT:C36639](http://purl.obolibrary.org/obo/NCIT_C36639) (ERBB2 Protein Overexpression) 54.17%
- [NCIT:C36548](http://purl.obolibrary.org/obo/NCIT_C36548) (Loss of Chromosome 2q) 54.17%
- [NCIT:C36516](http://purl.obolibrary.org/obo/NCIT_C36516) (Loss of Chromosome 10q) 54.17%
- [NCIT:C36496](http://purl.obolibrary.org/obo/NCIT_C36496) (Loss of Chromosome 18q) 54.17%
- [NCIT:C36489](http://purl.obolibrary.org/obo/NCIT_C36489) (Gain of Chromosome 5p) 54.17%
- [NCIT:C36480](http://purl.obolibrary.org/obo/NCIT_C36480) (Gain of Chromosome 20q) 54.17%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 54.17%
- [NCIT:C27712](http://purl.obolibrary.org/obo/NCIT_C27712) (Loss of Chromosome 5q) 54.17%
- [NCIT:C12866](http://purl.obolibrary.org/obo/NCIT_C12866) (Transitional Cell) 54.17%
- Thing 53.52%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 44.14%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C38345](http://purl.obolibrary.org/obo/NCIT_C38345) (JUN Pathway Deregulation))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C38344](http://purl.obolibrary.org/obo/NCIT_C38344) (RAS-RAF Pathway Deregulation))) 39.52%


